{"schema":"hottub-news/story/v1","story":"st_q5p2qzxpwtmlxvnjmsjq","title":"Recon: FDA approves Egetis' Emcitate for rare genetic disease; Novo buys rights to Chinese weight-loss pill in $2.6B deal","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/recon-fda-approves-egetis-emcitate-for-rare-genetic-disease-novo-buys-q5p2qzxpwt","count":1,"items":[{"id":"n_q5p2qzxpwtmlxvnjmsjq","seq":786709,"kind":"article","title":"Recon: FDA approves Egetis' Emcitate for rare genetic disease; Novo buys rights to Chinese weight-loss pill in $2.6B deal","url":"https://www.raps.org/resource/recon-fda-approves-egetis-emcitate-for-rare-genetic-disease-novo-buys-rights-to-chinese-weight-loss-pill-in-2-6b-deal.html","published":"2026-09-29T19:05:00Z","seen":"2026-09-29T23:23:20Z","lang":"en","source":{"id":"raps.org","name":"raps.org","domain":"raps.org"},"via":"gdelt-gkg-english","topics":["economy"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q818846","name":"Novo","type":"org"}],"story":"st_q5p2qzxpwtmlxvnjmsjq","category":"economy-business","category_p":0.8299999833106995,"sentiment":"positive","tone":-0.27000001072883606,"political":0.15000000596046448}]}